Doximity, Inc. (DOCS)
NYSE:DOCS
Want to see DOCS full AI Analyst Report?
DOCS Stock Chart & Stats
$24.71
-$0.33(-0.59%)
At close: 4:00 PM EST
$24.71
-$0.33(-0.59%)
Day’s Range― - ―
52-Week Range$17.15 - $76.51
Previous CloseN/A
Volume296.07K
Average Volume (3M)4.83M
Market Cap
$3.93B
Enterprise Value$3.79B
Total Cash (Recent Filing)$748.60M
Total Debt (Recent Filing)$10.19M
Price to Earnings (P/E)20.3
Beta1.48
Next Earnings
Aug 11, 2026EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.04
Shares Outstanding131,975,430
10 Day Avg. Volume4,448,239
30 Day Avg. Volume4,834,271
Financial Highlights & Ratios
PEG Ratio-1.89
Price to Book (P/B)4.58
Price to Sales (P/S)6.76
P/FCF Ratio13.72
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue5.88
Enterprise Value/Gross Profit6.60
Enterprise Value/Ebitda15.44
Forecast
1Y Price Target
$26.78Price Target Upside8.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering21
EPS Forecast (FY)1.43
Revenue Forecast (FY)$672.43M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthExtremely low leverage and a sizable equity/cash base materially reduce financial risk and preserve optionality. This durability supports continued buybacks, protects operating flexibility during ad-market cycles, and funds multi-year investments (AI, R&D) without compromising liquidity.
Cash GenerationConsistent, high free cash flow (multi-hundred million dollars) underpins durable capital allocation: funds R&D and AI compute, supports share repurchases, and cushions margin/booking volatility. Strong cash conversion enhances resilience versus cyclical ad demand.
High Margins & Customer RetentionExceptionally high gross margins and solid net margins, combined with multi-year revenue growth and high retention, indicate durable monetization. Large enterprise customers and strong NRR drive predictable recurring revenue and create a profitable base for upsell and product expansion.
Bears Say
Slowing Revenue GrowthA material deceleration in top-line growth reduces the company's organic expansion runway and raises pressure to show ROI from investments. Slower revenue momentum can lengthen payback for AI and sales investments and may require sustained higher spend to regain prior growth rates.
Margin Pressure From AI And SpendRising AI compute, higher R&D, marketing and elevated stock-based compensation create structural upward cost pressure as AI usage scales. These factors increase margin volatility and can compress operating profitability until AI monetization and efficiency gains offset higher operating intensity.
Delayed AI Monetization & VisibilityRegulatory reviews and slow product onboarding delay revenue realization from AI investments, limiting near-term upside despite adoption. Combined with softer bookings and HCP ad policy uncertainty, this reduces revenue visibility and extends the timeline to monetize AI-driven TAM expansion.
Doximity News
DOCS FAQ
What was Doximity, Inc.’s price range in the past 12 months?
Doximity, Inc. lowest stock price was $17.15 and its highest was $76.51 in the past 12 months.
What is Doximity, Inc.’s market cap?
Doximity, Inc.’s market cap is $3.93B.
When is Doximity, Inc.’s upcoming earnings report date?
Doximity, Inc.’s upcoming earnings report date is Aug 11, 2026 which is in 68 days.
How were Doximity, Inc.’s earnings last quarter?
Doximity, Inc. released its earnings results on May 13, 2026. The company reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.283 by -$0.023.
Is Doximity, Inc. overvalued?
According to Wall Street analysts Doximity, Inc.’s price is currently Undervalued.
Does Doximity, Inc. pay dividends?
Doximity, Inc. does not currently pay dividends.
What is Doximity, Inc.’s EPS estimate?
Doximity, Inc.’s EPS estimate is 0.3.
How many shares outstanding does Doximity, Inc. have?
Doximity, Inc. has 131,975,430 shares outstanding.
What happened to Doximity, Inc.’s price movement after its last earnings report?
Doximity, Inc. reported an EPS of $0.26 in its last earnings report, missing expectations of $0.283. Following the earnings report the stock price went down -23.001%.
Which hedge fund is a major shareholder of Doximity, Inc.?
Currently, no hedge funds are holding shares in DOCS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Doximity Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$26.78 (8.37% Upside)
$26.78 (8.37% Upside)
Blogger Sentiment
Bullish
DOCS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 112.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.23%
12-Months-Change
Fundamentals
Return on Equity
19.36%
Trailing 12-Months
Asset Growth
-11.00%
Trailing 12-Months
Company Description
Doximity, Inc.
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
DOCS Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlights strong financial health (record free cash flow, solid full-year revenue growth, high adjusted EBITDA and cash balance), robust engagement and rapid AI adoption across physicians and health systems, and meaningful early commercial traction for AI products. Offsetting these positives are near-term margin pressure from rising AI compute and investments, slower revenue guidance (~4% FY27 growth at midpoint), delayed AI monetization due to regulatory reviews, and softer bookings/visibility driven by policy and macro uncertainty. Management frames the year as an "AI investment year"—accepting short-term margin impact to capture a larger long-term TAM.View all DOCS earnings summariesDOCS Revenue Breakdown
93.00% Subscription
7.00% Other
DOCS Stock 12 Month Forecast
Average Price Target
$26.78
▲(8.37% Upside)
Technical Analysis
Omnicell
―
Evolent Health
―
Teladoc
―
Definitive Healthcare Corp
―
Tempus AI, Inc. Class A
―
Ownership Overview
2.93% Insiders
24.61% Mutual Funds
21.67% Other Institutional Investors
29.84% Public Companies and Individual Investors